trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['t-dxd', 'bcsm']
diving deep into the molecular mechanics of t-dxd in our latest study. aiming to shed light on the clinical phenomena observed in practice. looking forward to sharing insights at #asco23. #oncoalert #bcsm 
NCI-designated Univ of Hawai’i Cancer Ctr @UHCancerCenter, Director. Breast Med Oncologist. IBC. Tumor Microenvironment. Japanese Twitter @nuenojpn.